Prof. Dr. Dr. med. Thomas Thum

Prof. Thomas Thum studied Medicine and finished his Medical Doctorate Thesis in 2001 at the Medical School in Hannover. Since then he worked in different research laboratories in Hannover, London and Würzburg with a strong focus on molecular cardiology and heart failure research. He finalized a Ph.D. degree at the National Heart and Lung Institute at the Imperial College in London under supervision of Professor Philip Poole-Wilson. Since 2006, he led a research group entitled "Cardiac Wounding and Healing" at the Interdisciplinary Center of Clinical Research in Würzburg, Germany with a focus on experimental therapies for heart failure. His particular interests are transcription factors and microRNAs that orchestrate the complex genetic networks in individual cells important for cardiovascular homeostasis and disease. The research efforts of his group over the last years in the field of microRNA research were awarded by publication of several manuscripts in high-ranked international journals such as Nature, J Clin Invest, Circulation or Circulation Research. His group developed the first therapeutic use of microRNA antagonists ("antagomirs") to prevent cardiac fibrosis in various mouse models of cardiac stress (Nature, 2008;456:980-4; J Clin Invest, 2011, 121, 461-2). In October 2009 he was appointed as Full Professor (W3, permanent position) and Director of the Institute for Molecular and Translational Therapeutic Strategies (IMTTS; Medical School Hannover, Germany) with the main focus on cardiovascular translational medicine. In parallel, he is involved in clinical duties at the Department of Cardiology and Angiology (Prof. Bauersachs) in the field of heart failure and hypertrophic cardiomyopathies.

PD Dr. med. Michael Potente

Dr. Michael Potente is a research group leader and staff cardiologist at the Goethe University in Frankfurt / Germany. He was trained as a M.D. at the Universities of Frankfurt and Toronto with a major focus on cardiovascular physiology and medicine. For his experimental doctoral thesis, he worked under the mentorship of Prof. Dr. Rudi Busse at the Institute for Cardiovascular Physiology, where he obtained the doctoral degree in 04/2003 with honors (summa cum laude). After finishing his medical studies in 12/2002, he joined the Department of Cardiology at the University of Frankfurt (Prof. Dr. A.M. Zeiher), as it offered the possibility to combine clinical with postdoctoral training in the associated Institute of Cardiovascular Regeneration (Prof. Dr. S. Dimmeler). Dr. Potente received his board certification in Internal Medicine and Cardiology in 09/2011 and was appointed as attending physician in 10/2011. He received several national and international prizes including the prestigious Louis N. and Arnold M. Katz Basic Research Prize, awarded by the American Heart Association. Dr. Potente’s research program is devoted to the molecular analysis of transcriptional regulatory circuits that govern the growth, maintenance and regression of blood vessels. He has focused his efforts on the analysis of Foxo transcription factors and Notch signaling, two pivotal transcriptional regulators of vascular growth and homeostasis, as well as their regulation by reversible acetylation. In this context, his group explores specifically the function of sirtuins, which are NAD+-dependent deacetylases, for the dynamic regulation and adaptation of endothelial cell responses. Using conditional mouse mutants and in vivo models of vessel formation - combined with high-resolution imaging and state-of-the-art proteomics and genomics - his research aims to delineate novel regulatory pathways and mechanisms that control vascular growth and function in physiology and disease.
Prof. Dr. med. Nikos Sebastian Werner

Prof. Werner studierte Humanmedizin in Frankfurt am Main, Louisville und New York und promovierte 2000 in Frankfurt. Nach Assistenzarzt-Tätigkeit im Saarland wechselte er 2005 nach Bonn an die Medizinische Klinik II, wo er 2007 die Anerkennung zum Facharzt für Innere Medizin erhielt und die Weiterbildung für Kardiologie begann. 2008 habilitierte Prof. Werner und erwarb 2009 die Schwerpunkt-bezeichnung Kardiologie. Seitdem ist er Oberarzt und Leiter des Herzkatheterlabors. Im Juni übernahm er den Lehrstuhl für Molekulare Kardiologie. Seine wissenschaftlichen Forschungs-schwerpunkte sind die Atherogenese unter besonderer Berücksichtigung der endothelialen Regeneration zur Prävention atherosklerotischer Erkrankungen. Klinische Schwerpunkte sind die Interventionelle Kardiologie, der transkatheter-gestützte Herzklappenersatz und die Mechanismen der koronaren Atherosklerose. Prof. Werner ist u.a. Mitglied der Deutschen Gesellschaft für Kardiologie (DKG) und dort Sprecher der Arbeitsgemeinschaft "Vaskuläre Biologie" sowie Mitglied der AG "Interventionelle Kardiologie".

Prof. Dr. med. Tobias Geisler

Prof. Tobias Geisler studied Medicine at the Medical School in Marburg, Lund/Sweden and Cleveland/USA and finished his Medical Doctorate Thesis in 2003. After starting medical training in Marburg, he joined the group of Professor Meinrad Gawaz at the University Hospital Tübingen in 2005 with a strong focus on platelet research. He joined the group of Professor Marcus Flather at the Royal Brompton Hospital / Imperial College, London, United Kingdom as research fellow funded by the Atherothrombosis Grant of the European Society of Cardiology in 2009. Since 2011, he has been leading the Cardiovascular Clinical Research Unit at the University Hospital Tübingen, is principal investigator of several randomized clinical trials and leads a subproject of the DFG-Clinical Research Group KFO 274 Platelets Molecular Mechanisms. TG has a track record of high-rank peer reviewed publications and book publications in the field of antiplatelet pharmacology and pharmacogenetics. He has been awarded with national and international awards. In December 2010 he received his habilitation (Associate Professor). His main clinical focus is interventional cardiology.

Prof. Dr. med. Harald Langer

Prof. Harald Langer studied Medicine at the Otto-von-Guericke University in Magdeburg and the Technische University/German Heart Centre in Munich (Head Prof. Albert Schömig) and achieved his M.D. in 2004. Then he moved to the Department of Cardiology and Cardiovascular Medicine, Eberhard-Karls University Tübingen (Head Prof. Meinrad Gawaz). From 2007 to 2009 he was PostDoc at the National Institute of Health (NIH), National Cancer Institute (NCI), Experimental Immunology Branch (EIB, Head Alfred Singer), laboratory of Triantafyllos Chavakis (Inflammation Biology Section). Since then, he heads the Cardioimmunology Group in Tübingen. In 2011, he was appointed Professor for inflammatory heart disease at the University of Tübingen, when he was granted a Lichtenberg Professorship by the Volkswagen Foundation. At the same time, he was appointed as Coordinator of the Clinical Research Unit 274 (Platelets - Molecular Mechanisms and translational applications) established by the German Research Council. His particular scientific interest is in processes of inflammation and innate immunity in cardiovascular diseases, whereas his clinical focus is on clinical and interventional cardiology.
After a long planning phase KardioWIND e.V. was finally founded in 2011.